USPTO serial 90689916
SEQONE GENOMICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 15, 2022
- Examiner
- DAVIS, MARC STEPHEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEQONE GENOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Montpellier, FR
Montpellier, FR
Montpellier, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna CARTER, DELUCA AND FARRELL LLP576 BROAD HOLLOW RD.MELVILLE, NY 11747UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software Development Kits (SDKs); downloadable application programming interface (API) software; downloadable graphical user interface software used to describe, edit, and store instructions for executing software applications; downloadable computer programs and downloadable mobile device software for the creation of other software applications; downloadable computer programs and downloadable mobile device software for monitoring and interacting with other computer interfaces and programs; downloadable computer programs and downloadable mobile device software for describing, modifying, and storing instructions for running software applications; downloadable computer programs and downloadable mobile device software for monitoring and documenting other software applications and the inputs and outputs of those software applications; downloadable computer programs and downloadable mobile device software for connecting and collaborating with other users; downloadable computer programs and downloadable mobile device software for conducting genomic analyses; downloadable computer programs and downloadable mobile device software for uploading, sharing, storing, analyzing, managing, and transferring genomic data; downloadable computer programs and downloadable mobile device software for performing laboratory sequencing services, cancer diagnosis, sequence read assembly, sequence read alignment, detection and description of genetic mutations and variations, genotyping of samples, identification and quantification of isoforms, discovery and description of genetic background of a population discovery and description of disease progression in organisms and populations, discovery and description of genetic opportunity sets for a given population, subpopulation, species, variant or disease, generation and version control of simulated data sets and generation and version control of empirical genetic data sets; downloadable software for the collection, establishment, systematization and/or evaluation of genomic data | ACTIVE | — |
| 042 | Genomics research services; research and development services in the field of medical diagnostic tools and software; computer software design; computer software development; updating of computer software; software-as-a-service (SaaS) services featuring software for DNA sequencing for analysing digitised genomic data for diagnostic and therapeutic purposes; platform as a service (PaaS) featuring computer software platforms for DNA sequencing for analysing digitised genomic data for diagnostic and therapeutic purposes; computer services, namely, cloud hosting provider services; server hosting; Design and development of operating software for accessing and using a cloud computing network; Electronic data storage in the field of DNA sequencing for diagnostic and therapeutic purposes; Information technology (IT) consulting services; computer services, namely, remote management of information technology systems of others comprised of online searchable databases and algorithms for the management and delivery of scientific analysis results based on genomic data; quality control for others; monitoring computer systems for detecting unauthorized access or health data breaches | ACTIVE | — |
| 044 | Analysis of technical data in the field of DNA sequencing for diagnostic and therapeutic purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SEQONE S.A.S.
- Other trademarks owned by SEQONE S.A.S.
- Other trademarks owned by SEQONE S.A.S.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SEQONE GENOMICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 15, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 15, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 30, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 30, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 10, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 26, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jul 22, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 19, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| May 6, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| May 2, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 25, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 25, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 7, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 6, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2021 | NWAP | NEW APPLICATION ENTERED | — |